AU2002258519A1 - Compounds and methods for identifying, staging and treating cutaneous t-cell lymphoma - Google Patents

Compounds and methods for identifying, staging and treating cutaneous t-cell lymphoma

Info

Publication number
AU2002258519A1
AU2002258519A1 AU2002258519A AU2002258519A AU2002258519A1 AU 2002258519 A1 AU2002258519 A1 AU 2002258519A1 AU 2002258519 A AU2002258519 A AU 2002258519A AU 2002258519 A AU2002258519 A AU 2002258519A AU 2002258519 A1 AU2002258519 A1 AU 2002258519A1
Authority
AU
Australia
Prior art keywords
staging
identifying
compounds
methods
cell lymphoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002258519A
Inventor
Lars E. 7 Leon-Gaud French
Alain H. Rook
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania
Original Assignee
University of Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US27556201P priority Critical
Priority to US60/275,562 priority
Application filed by University of Pennsylvania filed Critical University of Pennsylvania
Priority to PCT/US2002/007847 priority patent/WO2002072032A2/en
Publication of AU2002258519A1 publication Critical patent/AU2002258519A1/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177Receptors; Cell surface antigens; Cell surface determinants
AU2002258519A 2001-03-14 2002-03-14 Compounds and methods for identifying, staging and treating cutaneous t-cell lymphoma Abandoned AU2002258519A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US27556201P true 2001-03-14 2001-03-14
US60/275,562 2001-03-14
PCT/US2002/007847 WO2002072032A2 (en) 2001-03-14 2002-03-14 Compounds and methods for identifying, staging and treating cutaneous t-cell lymphoma

Publications (1)

Publication Number Publication Date
AU2002258519A1 true AU2002258519A1 (en) 2002-09-24

Family

ID=23052835

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002258519A Abandoned AU2002258519A1 (en) 2001-03-14 2002-03-14 Compounds and methods for identifying, staging and treating cutaneous t-cell lymphoma

Country Status (2)

Country Link
AU (1) AU2002258519A1 (en)
WO (1) WO2002072032A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2511538C (en) 2002-12-30 2013-11-26 3M Innovative Properties Company Immunostimulatory combinations
JP3968383B2 (en) * 2004-09-01 2007-08-29 株式会社日本メディカル総研 New classification of blood cells as well as tailor-made treatment and prevention using the same
US8143029B2 (en) 2005-12-22 2012-03-27 Valipharma Methods and means related to diseases
MX2015008773A (en) * 2013-01-07 2015-11-06 Univ Pennsylvania Compositions and methods for treating cutaneous t cell lymphoma.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5962406A (en) * 1991-10-25 1999-10-05 Immunex Corporation Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same
US5747024A (en) * 1993-03-08 1998-05-05 Immunex Corporation Vaccine adjuvant comprising interleukin-15

Also Published As

Publication number Publication date
WO2002072032A3 (en) 2003-02-13
WO2002072032A2 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
AU2002308549A1 (en) Security system
AU7883700A (en) Methods and apparatus for treating teeth
AU4137601A (en) Methods, systems, and apparatuses for secure interactions
AU5646800A (en) Card-based biosensor device
AU2003297762A1 (en) Methods for treating essential tremor
AU2002245243A1 (en) Bone-treatment instrument and method
AU2002318157A1 (en) Method and system for portable retirement investment
AU2002359687A1 (en) Multiple laser treatment
AU2003248837A1 (en) Methods and devices for treating aneurysms
AU2002337596A1 (en) Cryoplasty apparatus and method
AU2002238076A1 (en) Endomural therapy
AU2001276926A1 (en) Method for treating multiple wellbore intervals
AU2002337711A1 (en) Systems, methods and apparatuses for manufacturing dosage forms
AU2003247355A1 (en) Process for identifying and treating specified cell types
AU2002237956A1 (en) Methods for surface modification
AU2002308751A1 (en) Authentication method
AU2002357091A8 (en) System and method for music inditification
AU2002315565A1 (en) Security system and method for computers
EP1440550B8 (en) Methods for multicasting content
AU2002364095A1 (en) Method and apparatus for simplified audio authentication
AU2002353904A1 (en) Method and device for delivering radiotherapy
AU2002316320A1 (en) Aneurysm treatment device
AU2003228481A1 (en) Groundwater treatment system and method
AU2002324432A1 (en) Analytical instruments, biosensors and methods thereof
AU6213001A (en) Method for oxidizing hydrocarbons

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase